Stuart Edmonds (he/him)
@stuart365.bsky.social
cancer, research, policy, patient engagement, knowledge translation. tennis, running, golf & football views my own.
mRNA vaccines seem to boost the effectiveness of an immune therapy for skin and lung cancer ― in an unexpected way in @nature.com www.nature.com/articles/d41...
People with some cancers live longer after a COVID vaccine
mRNA vaccines seem to boost the effectiveness of an immune therapy for skin and lung cancer ― in an unexpected way.
www.nature.com
November 13, 2025 at 11:52 AM
mRNA vaccines seem to boost the effectiveness of an immune therapy for skin and lung cancer ― in an unexpected way in @nature.com www.nature.com/articles/d41...
Reposted by Stuart Edmonds (he/him)
#ESMO25: 177Lu-PSMA-617 with ADT plus ARPI showed PFS benefit in hormone-sensitive #ProstateCancer (#HSPC) but no improvement seen with 177Lu-PSMA-617 vs docetaxel in castration-resistant prostate cancer (#mCRPC) after ARPI.
#ESMODailyReporter ➡️ https://ow.ly/2C0e50XeAoj
#ESMODailyReporter ➡️ https://ow.ly/2C0e50XeAoj
October 19, 2025 at 3:45 PM
#ESMO25: 177Lu-PSMA-617 with ADT plus ARPI showed PFS benefit in hormone-sensitive #ProstateCancer (#HSPC) but no improvement seen with 177Lu-PSMA-617 vs docetaxel in castration-resistant prostate cancer (#mCRPC) after ARPI.
#ESMODailyReporter ➡️ https://ow.ly/2C0e50XeAoj
#ESMODailyReporter ➡️ https://ow.ly/2C0e50XeAoj
Reposted by Stuart Edmonds (he/him)
Men with BRCA1 and BRCA2 mutations should get annual #ProstateCancer screening.
The IMPACT trial finds BRCA1 carriers are 3 times more likely to have aggressive prostate cancers than non-carriers.
Results from the international trial shared at @myesmo.bsky.social
www.icr.ac.uk/about-us/icr...
The IMPACT trial finds BRCA1 carriers are 3 times more likely to have aggressive prostate cancers than non-carriers.
Results from the international trial shared at @myesmo.bsky.social
www.icr.ac.uk/about-us/icr...
October 17, 2025 at 8:05 AM
Men with BRCA1 and BRCA2 mutations should get annual #ProstateCancer screening.
The IMPACT trial finds BRCA1 carriers are 3 times more likely to have aggressive prostate cancers than non-carriers.
Results from the international trial shared at @myesmo.bsky.social
www.icr.ac.uk/about-us/icr...
The IMPACT trial finds BRCA1 carriers are 3 times more likely to have aggressive prostate cancers than non-carriers.
Results from the international trial shared at @myesmo.bsky.social
www.icr.ac.uk/about-us/icr...
“Fragmentomics” has opened new opportunities in noninvasive cancer diagnostics. Excellent review in @cp-cancercell.bsky.social by Dennis Lo of #CUHKMedicine www.cell.com/cancer-cell/...
Cell-free DNA fragmentomics in cancer
The analysis of cell-free DNA (cfDNA) fragmentation patterns, known as “fragmentomics,”
has opened new opportunities in noninvasive cancer diagnostics. In this Review, Tsui
et al. explore the exciting...
www.cell.com
October 16, 2025 at 7:39 PM
“Fragmentomics” has opened new opportunities in noninvasive cancer diagnostics. Excellent review in @cp-cancercell.bsky.social by Dennis Lo of #CUHKMedicine www.cell.com/cancer-cell/...
"I find it very, very difficult to think that just because people have a certain kind of privilege they can be treated. It's unfair," Sir Steve McQueen in a new call for targeted prostate cancer testing in the UK www.bbc.com/news/article.... We need to do better in Canada too.
Rishi Sunak: Prostate cancer screening could 'save countless lives'
The former PM is among those in favour of targeted screening for men most at risk, but some medical experts are sceptical.
www.bbc.com
October 14, 2025 at 2:48 PM
"I find it very, very difficult to think that just because people have a certain kind of privilege they can be treated. It's unfair," Sir Steve McQueen in a new call for targeted prostate cancer testing in the UK www.bbc.com/news/article.... We need to do better in Canada too.
All fluffed up: why modern balls are sparking injury worries and frustration in tennis. Great piece by @tumcarayol.bsky.social. Not all tennis balls are equal. www.theguardian.com/sport/2025/o...
All fluffed up: why modern balls are sparking injury worries and frustration in tennis
Daniil Medvedev is one of a growing number of leading players who say that the balls have become unpredictable and are affecting their game
www.theguardian.com
October 10, 2025 at 5:31 PM
All fluffed up: why modern balls are sparking injury worries and frustration in tennis. Great piece by @tumcarayol.bsky.social. Not all tennis balls are equal. www.theguardian.com/sport/2025/o...
Quantitative assessment of the radon (222Rn) decay product 210Pb in human toenails as a sensitive measure of personalized long-term radon gas exposure history. www.sciencedirect.com/science/arti... Important research from @ucalgarymed.bsky.social funded by @cancersociety.bsky.social
Quantitative assessment of the radon (222Rn) decay product 210Pb in human toenails as a sensitive measure of personalized long-term radon gas exposure history
Lung cancer mortality can be lowered through early-diagnostic screening of people demonstrating a ≥1.5 % 6-year risk of tumor development. However, ma…
www.sciencedirect.com
October 9, 2025 at 3:27 PM
Quantitative assessment of the radon (222Rn) decay product 210Pb in human toenails as a sensitive measure of personalized long-term radon gas exposure history. www.sciencedirect.com/science/arti... Important research from @ucalgarymed.bsky.social funded by @cancersociety.bsky.social
Another great piece by @caulfieldtim.bsky.social this time on UPFs - however we’re defining them thewalrus.ca/sure-ultra-p...
Sure, Ultra-Processed Foods Are Bad. But How Does That Help Anyone? | The Walrus
Nutrition panic distracts from the policies that make healthy eating a privilege
thewalrus.ca
October 8, 2025 at 7:33 PM
Another great piece by @caulfieldtim.bsky.social this time on UPFs - however we’re defining them thewalrus.ca/sure-ultra-p...
Niraparib and abiraterone acetate plus prednisone for HRR-deficient metastatic castration-sensitive prostate cancer: a randomized phase 3 trial in @natmed.nature.com www.nature.com/articles/s41...
Niraparib and abiraterone acetate plus prednisone for HRR-deficient metastatic castration-sensitive prostate cancer: a randomized phase 3 trial - Nature Medicine
In the randomized phase 3 AMPLITUDE trial, patients with HRR-deficient mCSPC experienced longer progression-free survival when they were treated with niraparib and AAP compared to placebo and AAP.
www.nature.com
October 8, 2025 at 7:28 PM
Niraparib and abiraterone acetate plus prednisone for HRR-deficient metastatic castration-sensitive prostate cancer: a randomized phase 3 trial in @natmed.nature.com www.nature.com/articles/s41...
Reposted by Stuart Edmonds (he/him)
New transatlantic cancer research funding!
We're partnering with @ccsresearch.bsky.social to co-fund our Biology to Prevention Award, doubling the funding for collaborative UK and Canadian prevention research teams.
Join our webinar on 28 October at 14:00 GMT to learn more: cruk.ink/46yjOBX
We're partnering with @ccsresearch.bsky.social to co-fund our Biology to Prevention Award, doubling the funding for collaborative UK and Canadian prevention research teams.
Join our webinar on 28 October at 14:00 GMT to learn more: cruk.ink/46yjOBX
Webinar: Biology to Prevention Award co-funded with Canadian Cancer Society
Join our webinar on 28 October to learn about this new partnership and how to apply for co-funding through the Biology to Prevention Award
cruk.ink
October 8, 2025 at 9:35 AM
New transatlantic cancer research funding!
We're partnering with @ccsresearch.bsky.social to co-fund our Biology to Prevention Award, doubling the funding for collaborative UK and Canadian prevention research teams.
Join our webinar on 28 October at 14:00 GMT to learn more: cruk.ink/46yjOBX
We're partnering with @ccsresearch.bsky.social to co-fund our Biology to Prevention Award, doubling the funding for collaborative UK and Canadian prevention research teams.
Join our webinar on 28 October at 14:00 GMT to learn more: cruk.ink/46yjOBX
Metastases-directed therapy in addition to standard systemic therapy in oligometastatic castration-resistant prostate cancer in Canada (GROUQ-PCS 9): a multicentre, open-label, randomised, phase 2 trial www.sciencedirect.com/science/arti...
October 3, 2025 at 4:17 PM
Metastases-directed therapy in addition to standard systemic therapy in oligometastatic castration-resistant prostate cancer in Canada (GROUQ-PCS 9): a multicentre, open-label, randomised, phase 2 trial www.sciencedirect.com/science/arti...
Health-care transitions for young people living beyond childhood and adolescent cancer: recommendations from the EU–CAYAS–NET consortium in @thelancetoncol.bsky.social www.sciencedirect.com/science/arti...
Health-care transitions for young people living beyond childhood and adolescent cancer: recommendations from the EU–CAYAS–NET consortium
Childhood and adolescent cancer survivors (age at diagnosis: 0–21 years) face increased risk for long-term health complications and less favourable ou…
www.sciencedirect.com
October 3, 2025 at 4:16 PM
Health-care transitions for young people living beyond childhood and adolescent cancer: recommendations from the EU–CAYAS–NET consortium in @thelancetoncol.bsky.social www.sciencedirect.com/science/arti...
Tilly Norwood: how scared should we be of the viral AI ‘actor’? www.theguardian.com/film/2025/se...
Tilly Norwood: how scared should we be of the viral AI ‘actor’?
A bunch of code is being pushed as the next Scarlett Johansson, a creation that is already causing pushback from real human actors
www.theguardian.com
October 2, 2025 at 4:18 PM
Tilly Norwood: how scared should we be of the viral AI ‘actor’? www.theguardian.com/film/2025/se...
The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023 - The Lancet www.thelancet.com/journals/lan...
The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023
Cancer is a major contributor to global disease burden, with increasing numbers of
cases and deaths forecasted up to 2050 and a disproportionate growth in burden in
countries with scarce resources. Th...
www.thelancet.com
October 2, 2025 at 11:54 AM
The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023 - The Lancet www.thelancet.com/journals/lan...
Early-onset colorectal cancer as an emerging disease of metabolic dysregulation in @natrevendo.nature.com bit.ly/3KyGwT0
Early-onset colorectal cancer as an emerging disease of metabolic dysregulation
Nature Reviews Endocrinology - Cases of early-onset colorectal cancer (EOCRC) have risen alarmingly since the 1990s, alongside a surge in metabolic diseases, particularly obesity and type 2...
www.nature.com
October 1, 2025 at 10:55 AM
Early-onset colorectal cancer as an emerging disease of metabolic dysregulation in @natrevendo.nature.com bit.ly/3KyGwT0
Reposted by Stuart Edmonds (he/him)
NOMINATIONS ARE OPEN: Do you know someone making a big impact in #cancer #research in Canada? Help us celebrate their work by nominating them for the 2025 @cancersociety.bsky.social Awards for Excellence in Cancer Research!
Deadline to nominate: December 10, 2025 at 5 pm EST
Deadline to nominate: December 10, 2025 at 5 pm EST
September 26, 2025 at 4:24 PM
NOMINATIONS ARE OPEN: Do you know someone making a big impact in #cancer #research in Canada? Help us celebrate their work by nominating them for the 2025 @cancersociety.bsky.social Awards for Excellence in Cancer Research!
Deadline to nominate: December 10, 2025 at 5 pm EST
Deadline to nominate: December 10, 2025 at 5 pm EST
Reposted by Stuart Edmonds (he/him)
Clinical trials gain intelligence go.nature.com/46HLHci
July 15, 2025 at 9:04 PM
Clinical trials gain intelligence go.nature.com/46HLHci
‘I was told I had two weeks to live’ – why are so many young, fit, non-smoking women getting lung cancer? www.theguardian.com/society/2025...
‘I was told I had two weeks to live’ – why are so many young, fit, non-smoking women getting lung cancer?
For decades, lung cancer has been viewed as a disease of older men who smoked. Now, cases among young women are on the rise and doctors are baffled. Could air pollution be behind it?
www.theguardian.com
September 14, 2025 at 4:05 PM
‘I was told I had two weeks to live’ – why are so many young, fit, non-smoking women getting lung cancer? www.theguardian.com/society/2025...
The landscape of microbial associations in human cancer | Science Translational Medicine www.science.org/doi/10.1126/...
The landscape of microbial associations in human cancer
Differences between cancer types, infectious disease, and potential prognostic markers are uncovered by studying microbes within cancer DNA.
www.science.org
September 10, 2025 at 10:51 AM
The landscape of microbial associations in human cancer | Science Translational Medicine www.science.org/doi/10.1126/...
Reposted by Stuart Edmonds (he/him)
UHN has successfully completed two Neuralink brain implant surgeries. This marks a major advancement in neurosurgery and unlocks new possibilities for spinal cord injury patients, helping them access new functions and regain independence.
Learn more: https://bit.ly/3V5QYDE
Learn more: https://bit.ly/3V5QYDE
Toronto doctors implant Canada's first Neuralink Brain Chip
A tiny brain chip is giving Canadians with paralysis the power to control technology using nothing but their thoughts. Melissa Nakhavoly with more on the historic procedure.
bit.ly
September 5, 2025 at 6:00 PM
UHN has successfully completed two Neuralink brain implant surgeries. This marks a major advancement in neurosurgery and unlocks new possibilities for spinal cord injury patients, helping them access new functions and regain independence.
Learn more: https://bit.ly/3V5QYDE
Learn more: https://bit.ly/3V5QYDE
Prostate cancer is the most common cancer among men in the United States, and the incidence of advanced disease is increasing rapidly. acsjournals.onlinelibrary.wiley.com/doi/full/10....
Prostate cancer statistics, 2025
Prostate cancer is the most common cancer among men in the United States, and the incidence of advanced disease is increasing rapidly. This article provides an overview of prostate cancer occurrence ....
acsjournals.onlinelibrary.wiley.com
September 6, 2025 at 2:43 AM
Prostate cancer is the most common cancer among men in the United States, and the incidence of advanced disease is increasing rapidly. acsjournals.onlinelibrary.wiley.com/doi/full/10....
NHS may struggle to cope with more than 6 million predicted new cases over next 15 years, study shows www.theguardian.com/society/2025...
Cancer charities call for earlier diagnosis as cases projected to surge in England by 2040
NHS may struggle to cope with more than 6 million predicted new cases over next 15 years, study shows
www.theguardian.com
August 27, 2025 at 10:05 AM
NHS may struggle to cope with more than 6 million predicted new cases over next 15 years, study shows www.theguardian.com/society/2025...
The silent epidemic: the pros and cons of screening for prostate cancer www.theguardian.com/wellness/202...
The silent epidemic: the pros and cons of screening for prostate cancer
In the US, prostate cancer is the second leading cause of cancer death in men – but experts can’t agree about testing
www.theguardian.com
August 20, 2025 at 11:54 AM
The silent epidemic: the pros and cons of screening for prostate cancer www.theguardian.com/wellness/202...
Ontario cancer survivor celebrates birthday by paying for patients’ hospital parking | Globalnews.ca globalnews.ca/news/1133098...
Global News | Breaking, Latest News and Video for Canada
Globalnews.ca – Watch and read Canada’s Breaking news plus Business, Health, Politics and World News
Globalnews.ca
August 12, 2025 at 6:41 PM
Ontario cancer survivor celebrates birthday by paying for patients’ hospital parking | Globalnews.ca globalnews.ca/news/1133098...
Rethinking relief: Targeting sensory neurons to combat cancer and pain: Cancer Cell www.cell.com/cancer-cell/...
Rethinking relief: Targeting sensory neurons to combat cancer and pain
Cancer pain is a complex problem that, when left unaddressed, can impact overall survival
and decrease patients’ quality of life. Collaboration among medical oncologists, immunologists,
and neurobiolo...
www.cell.com
August 11, 2025 at 2:30 PM
Rethinking relief: Targeting sensory neurons to combat cancer and pain: Cancer Cell www.cell.com/cancer-cell/...